Acinetobacter baumannii has emerged in the last decades as a major cause of healthcare-associated infections and nosocomial outbreaks. Multidrug-resistant (MDR) A. baumannii is a rapidly emerging ...
The Global Acinetobacter Pneumonia Therapeutics Market is valued at approximately USD 300.81 million in 2023 and is projected to expand at a compound annual growth rate (CAGR) of over 6.40% from 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results